| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.08 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.09 | 0.09 |